NCT03271008

Brief Summary

Comparison of various videolaryngoscope devices (Vividtrac™ and KingVision™) and direct laryngoscopy with Macintosh blade regarding laryngoscopy time, intubation time, intubation success rate, percentage of visible glottic opening (POGO score) in elective and acute clinical anaesthesiology practice.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2017

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2017

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

May 11, 2017

Completed
4 months until next milestone

First Posted

Study publicly available on registry

September 1, 2017

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2018

Completed
Last Updated

September 1, 2017

Status Verified

August 1, 2017

Enrollment Period

1.5 years

First QC Date

May 11, 2017

Last Update Submit

August 31, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Intubation time

    Time necessary to secure airway during the induction of general anesthesia. Intubation time is measured from the point the airway device crosses the interdental line until the completion of intubation with insufflated cuffed endotracheal tube (secured airway).

    Measured once during the intubation attempt. Up to 120 seconds following the start of intubation attempt.

Secondary Outcomes (4)

  • Laryngoscopy time

    Registered once during the intubation attempt. Up to 120 seconds following the start of intubation attempt.

  • Percentage of glottic opening (POGO) score

    Registered once during the intubation attempt. Up to 120 seconds following the start of intubation attempt.

  • Tube insertion time

    Registered once during the intubation attempt. Up to 120 seconds following the start of intubation attempt.

  • Primary intubation attempt success rate

    Measured once after intubation. Up to 120 seconds following the start of intubation attempt.

Study Arms (3)

Macintosh laryngoscopy

ACTIVE COMPARATOR

In this group intubation attempt is carried out with a standard Macintosh (size 3 or 4) direct laryngoscopy blade.

Device: Direct laryngoscopy

KingVision videolaryngoscope

ACTIVE COMPARATOR

In this group intubation attempt is carried out with KingVision videolaryngoscope with a channeled, disposable single-use blade.

Device: KingVision videolaryngoscope

VividTrac videolaryngoscope

ACTIVE COMPARATOR

In this group intubation attempt is carried out with VividTrac Adult model using a smartphone or laptop running the VividVision proprietary software.

Device: Vividtrac videolaryngoscope

Interventions

During the induction of general anaesthesia, the first attempt to achieve a secured airway is carried out using a size 4 (or size 3 if necessary) Macintosh blade direct laryngoscope.

Macintosh laryngoscopy

During the induction of general anaesthesia, the first attempt to achieve a secured airway is carried out using a Vividtrac videolaryngoscope connected to a tablet or smartphone.

VividTrac videolaryngoscope

During the induction of general anaesthesia, the first attempt to achieve a secured airway is carried out using a KingVision videolaryngoscope.

KingVision videolaryngoscope

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • written informed consent
  • over 18 years of age
  • elective intervention
  • no anticipated difficult airway or intubation
  • preoperative anaesthesia risk assessment by American Society of Anaesthesiologists (ASA) physical status classification: ASA grade I-II

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Pécs, Dept. of Anaesthesia and Intensive Care

Pécs, Baranya, 7622, Hungary

RECRUITING

Related Publications (1)

  • Rendeki S, Keresztes D, Woth G, Merei A, Rozanovic M, Rendeki M, Farkas J, Muhl D, Nagy B. Comparison of VividTrac(R), Airtraq(R), King Vision(R), Macintosh Laryngoscope and a Custom-Made Videolaryngoscope for difficult and normal airways in mannequins by novices. BMC Anesthesiol. 2017 May 26;17(1):68. doi: 10.1186/s12871-017-0362-y.

    PMID: 28549421BACKGROUND

Study Officials

  • Bálint Nagy, MD PhD

    Department of Anesthesiology and Intensive Therapy, University of Pécs, Hungary

    STUDY CHAIR
  • Szilárd Rendeki, MD

    Department of Anesthesiology and Intensive Therapy, University of Pécs, Hungary

    STUDY CHAIR
  • Lajos Bogár, MD PhD DSc

    Department of Anesthesiology and Intensive Therapy, University of Pécs, Hungary

    STUDY CHAIR

Central Study Contacts

Gábor Woth, MD PhD

CONTACT

Dóra Keresztes, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Following informed consent participants are randomised into one of the device groups and general anaesthesia is induced. Primary intubation attempt is carried out with the randomised device. We do not disclose the result of randomisation with our participants prior to anaesthesia induction. Participants are already in surgical anaesthesia with muscle relaxation during the intubation attempt. As providers are the users of the intubation device masking is not possible in this regard. During outcome assessment we plan not to disclose which device was used for a certain group.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
clinical resident, PhD

Study Record Dates

First Submitted

May 11, 2017

First Posted

September 1, 2017

Study Start

January 1, 2017

Primary Completion

July 1, 2018

Study Completion

July 1, 2018

Last Updated

September 1, 2017

Record last verified: 2017-08

Data Sharing

IPD Sharing
Will not share

Locations